Barbital

Barbital

SCHEMBL1650201

CCC1(CC)C(=O)NC(=O)NC1=O.Nc1nc(Nc2ccccc2)nc(Nc2ccccc2)n1

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.48
▸ KMT2A Q03164 3/20 0.48
▸ NPC1 O15118 3/20 0.48
▸ RAB9A P51151 3/20 0.48
▸ HTT P42858 2/20 0.48
▸ LMNA P02545 2/20 0.45
▸ GAA P10253 4/20 0.43
▸ KDM4E B2RXH2 2/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ ALDH1A1 P00352 3/20 0.43
▸ GFER P55789 1/20 0.42
▸ BCL6 P41182 1/20 0.42
▸ KCNH3 Q9ULD8 2/20 0.42
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ CYP1A2 P05177 2/20 0.41
▸ CYP3A4 P08684 2/20 0.41
▸ CYP2C9 P11712 2/20 0.41
▸ CYP2D6 P10635 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Barbital SCHEMBL1649531 0.88 RAB9A (0.51) MAPTKMT2ANPC1RAB9AHTT
Barbital SCHEMBL1650226 0.87 AGPAT2 (0.43) MAPTKMT2ANPC1RAB9AHTT
Barbital SCHEMBL1649517 0.87 LMNA (0.42) MAPTKMT2ANPC1RAB9AHTT
Barbital SCHEMBL1650202 0.87 AGPAT2 (0.46) MAPTKMT2ANPC1RAB9AHTT
Barbital SCHEMBL1649164 0.87 RAB9A (0.55) MAPTKMT2ANPC1RAB9AHTT
Barbital SCHEMBL1648828 0.86 MAPT (0.49) MAPTKMT2ANPC1RAB9ALMNA
Barbital SCHEMBL1648863 0.79 NFKB1 (0.40) NPC1RAB9A
Barbital SCHEMBL9275277 0.77 LMNA (0.57) KMT2ALMNAMEN1ALDH1A1TDP1
SCHEMBL2253957 0.76 GAA (0.69) MAPTKMT2ANPC1RAB9AHTT
Barbital SCHEMBL1649158 0.75 LMNA (0.50) MAPTKMT2ALMNAKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1608339-B8 PHARMACEUTICAL CO-CRYSTAL OF CELECOXIB-NICOTINAMIDE MCNEIL PPC INC (US) 2012-04-25 — — EP disclosed
US-7927613-B2 Pharmaceutical co-crystal compositions UNIVERSITY OF SOUTH FLORIDA (US) 2011-04-19 — — US disclosed
US-20100311701-A1 Pharmaceutical Co-Crystal Compositions TRANSFORM PHARMACEUTICALS, INC (US) 2010-12-09 — — US disclosed
US-20070059356-A1 Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen REGENTS OF THE UNIVERSITY OF MICHIGAN, THE 2007-03-15 — — US disclosed
US-20070026078-A1 Pharmaceutical co-crystal compositions TRANSFORM PHARMACEUTICALS, INC. (US) 2007-02-01 — — US disclosed
EP-1608339-A1 PHARMACEUTICAL CO-CRYSTAL COMPOSITIONS OF DRUGS SUCH AS CARBAMAZEPINE, CELECOXIB, OLANZAPINE, ITRACONAZOLE, TOPIRAMATE, MODAFINIL, 5-FLUOROURACIL, HYDROCHLOROTHIAZIDE, ACETAMINOPHEN, ASPIRIN, FLURBIPROFEN, PHENYTOIN AND IBUPROFEN Transform Pharmaceuticals, Inc. (US) 2005-12-28 — — EP disclosed
WO-2004078161-A1 PHARMACEUTICAL CO-CRYSTAL COMPOSITIONS OF DRUGS SUCH AS CARBAMAZEPTINE, CELECOXIB, OLANZAPINE, ITRACONAZOLE, TOPIRAMATE, MODAFINIL, 5-FLUOROURACIL, HYDROCHLOROTHIAZIDE, ACETAMINOPHEN, ASPIRIN, FLURBIPROFEN, PHENYTOIN AND IBUPROFEN TRANSFORM PHARMACEUTICALS, INC. (US) 2004-09-16 — — WO disclosed
Send feedback